Imperagen
It develops AI and quantum-powered enzyme engineering technology and is using seed funding to scale its platform.
Overview
Imperagen is a Manchester-based deep tech company building an AI and quantum-powered approach to enzyme engineering. Its work targets customers and partners seeking engineered enzymes, with the company positioning its platform around computational methods for enzyme design and development. The company raised a £5 million ($6.7 million) Seed round in May 2026, led by PXN Ventures with participation from IQ Capital and Northern Gritstone. The financing is intended to help scale its enzyme engineering platform and supports its differentiation at the intersection of artificial intelligence, quantum computing and biotechnology.
Funding History
Manchester Imperagen raises €5.8 million Seed to scale AI and quantum-powered enzyme engineering
Frequently Asked Questions
- How much funding does AI Funding track for Imperagen?
- AI Funding tracks $7M for Imperagen across 1 funding round in this database.
- Who are Imperagen's investors?
- Imperagen's investors include PXN Ventures, IQ Capital, Northern Gritstone.
- What does Imperagen do?
- Imperagen is a Manchester-based deep tech company building an AI and quantum-powered approach to enzyme engineering. Its work targets customers and partners seeking engineered enzymes, with the company positioning its platform around computational methods for enzyme design and development. The company raised a £5 million ($6.7 million) Seed round in May 2026, led by PXN Ventures with participation from IQ Capital and Northern Gritstone. The financing is intended to help scale its enzyme engineering platform and supports its differentiation at the intersection of artificial intelligence, quantum computing and biotechnology.
- Where is Imperagen headquartered?
- Imperagen is headquartered in Manchester, United Kingdom.
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.